NHS England updates CDF List
NHS England updates CDF List
NHS England has updated the Cancer Drugs Fund List. The latest version (v1.405) was uploaded to the NHS England Website on Thursday 25, June 2026.
The following changes have been introduced:
Pembrolizumab with chemoradiotherapy (PEMB36)
Pembrolizumab with chemoradiotherapy for untreated locally advanced cervical cancer where the following criteria have been met
Recommended for routine commissioning, receiving CDF interim funding
Daratumumab in combination (with bortezomib, lenalidomide, and dexamethasone) (DAR6)
For UNTREATED multiple myeloma when a stem cell transplant is UNSUITABLE where the following criteria have been met
Date moving into routine commissioning updated
Mirvetuximab soravtansine (MIR1)
For treating folate receptor-alpha-positive platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer where the following criteria have been met
Date moving into routine commissioning updated